Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV Events

JACC-CARDIOVASCULAR IMAGING

卷:6

Article

Figueroa, Amparo L.^1,2,3  Abdelbaky, Amr^1,2,3  Truong, Quynh A.^1,2,3,4  Corsini, Erin^1,2,3  MacNabb, Megan H.^1,2,3  Lavender, Zachary R.^1,2,3  Lawler, Meredith A.^1,2,3  Grinspoon, Steven K.^3,5  Brady, Thomas J.^1,2,3  Nasir, Khurram^6,7  Hoffmann, Udo^1,2,3  Tawakol, Ahmed^1,2,3,4 

[1] Massachusetts Gen Hosp, Dept Imaging, Cardiac MR PET CT Program, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA

[6] Florida Int Univ, Robert Stempel Coll Publ Hlth,Herbert Wertheim Co, Dept Med,Dept Epidemiol, Ctr Prevent & Wellness Res,Baptist Hlth South Flo, Miami, FL 33199 USA

[7] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiol, Baltimore, MD USA

关键词: cardiovascular events;    FDG-PET;    inflammation;    risk factors;   

DOI  :  10.1016/j.jcmg.2013.08.006

来源: Elsevier

【 摘 要 】

OBJECTIVES This study sought to determine whether arterial inflammation measured by F-18-fluoro-deoxyglucose positron emission tomography (F-18-FDG-PET) improves prediction of cardiovascular disease (CVD) beyond traditional risk factors. BACKGROUND It is unknown whether arterial F-18-FDG uptake measured with routine PET imaging provides incremental value for predicting CVD events beyond Framingham risk score (FRS). METHODS We consecutively identified 513 individuals from 6,088 patients who underwent F-18-FDG-PET and computed tomography (CT) imaging at Massachusetts General Hospital between 2005 and 2008 and who met additional inclusion criteria: >= 30 years of age, no prior CVD, and free of cancer. CVD events were independently adjudicated, while blinded to clinical data, using medical records to determine incident stroke, transient ischemic attack, acute coronary syndrome, revascularization, new-onset angina, peripheral arterial disease, heart failure, or CVD death. FDG uptake was measured in the ascending aorta (as target-to-background-ratio [TBR]), while blinded to clinical data. RESULTS During follow-up (median 4.2 years), 44 participants developed CVD (2 per 100 personyears at risk). TBR strongly predicted subsequent CVD independent of traditional risk factors (hazard ratio: 4.71; 95% confidence interval [Cl]: 1.98 to 11.2; p < 0.001) and (hazard ratio: 4.13; 95% Cl: 1.59 to 10.76; p = 0.004) after further adjustment for coronary calcium score. Addition of arterial PET measurement to FRS scores improved the C-statistic (mean standard error 0.62 +/- 0.03 vs. 0.66 +/- 0.03). Further, incorporation of TBR into a model with FRS variables resulted in an integrated discrimination of 5% (95% Cl: 0.36 to 9.87). Net reclassification improvements were 27.48% (95% Cl: 16.27 to 39.92) and 22.3% (95% Cl: 11.54 to 35.42) for the 10% and 6% intermediate-risk cut points, respectively. Moreover, TBR was inversely associated with the timing of CVD (beta -0.096; p < 0.0001). CONCLUSIONS Arterial FDG uptake, measured from routinely obtained PET/CT images, substantially improved incident CVD prediction beyond FRS among individuals undergoing cancer surveillance and provided information on the potential timing of such events. (C) 2013 by the American College of Cardiology Foundation

【 授权许可】

Free